Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
Brown University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Mayo Clinic
Weill Medical College of Cornell University
Scripps Translational Science Institute
Washington University School of Medicine
Hackensack Meridian Health
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Takeda
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Emory University
OHSU Knight Cancer Institute
University of Nebraska
Amgen
Bristol-Myers Squibb
University of Michigan Rogel Cancer Center
Northside Hospital, Inc.
National Cancer Institute (NCI)
Kiadis Pharma
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Arizona